1. Tasquinimod: A Novel Angiogenesis Inhibitor–Development in Prostate Cancer

   • Saby George
   • Roberto Pili

   Evolving Therapies (RM Bukowski, Section Editor) 20 January 2013 Pages: 65 - 68

   

2. Enzalutamide, a Second Generation Androgen Receptor Antagonist: Development and Clinical Applications in Prostate Cancer

   • Manoj P. Menon
   • Celestia S. Higano

   Evolving Therapies (RM Bukowski, Section Editor) 23 January 2013 Pages: 69 - 75

   

3. Cabozantinib as a Novel Therapy for Renal Cell Carcinoma

   • Ulka Vaishampayan

   Evolving Therapies (RM Bukowski, Section Editor) 05 January 2013 Pages: 76 - 82

4. Foretinib (XL880): c-MET Inhibitor with Activity in Papillary Renal Cell Cancer

   • Theodore F. Logan

   Evolving Therapies (RM Bukowski, Section Editor) 14 February 2013 Pages: 83 - 90

5. Regorafenib (BAY 73–4506): Stromal and Oncogenic Multikinase Inhibitor with Potential Activity in Renal Cell Carcinoma

   • Kamarul Zaki
   • Shahzeena Aslam
   • Tim Eisen

   Evolving Therapies (RM Bukowski, Section Editor) 20 January 2013 Pages: 91 - 97

   

6. Programmed Death 1 Pathway inhibition in Metastatic Renal Cell Cancer and Prostate Cancer

   • Patricia A. Tang
   • Daniel Y. C. Heng

   Evolving Therapies (RM Bukowski, Section Editor) 22 December 2012 Pages: 98 - 104

   

7. Targeting the Adrenal Gland in Castration-Resistant Prostate Cancer: A Case for Orteronel, a Selective CYP-17 17,20-Lyase Inhibitor

   • Hui Zhu
   • Jorge A. Garcia

   Evolving Therapies (RM Bukowski, Section Editor) 31 January 2013 Pages: 105 - 112

   

8. Custirsen (OGX-011): Clusterin Inhibitor in Metastatic Prostate Cancer

   • Sohaib Al-Asaaed
   • Eric Winquist

   Evolving Therapies (RM Bukowski, Section Editor) 25 December 2012 Pages: 113 - 118

9. Assessment of Treatment Response after Chemoradiation of Head and Neck Cancer

   • Fernando Luiz Dias

   Head and Neck Cancers (EY Hanna, Section Editor) 08 January 2013 Pages: 119 - 127

10. Perineural Invasion of Head and Neck Skin Cancer: Diagnostic and Therapeutic Implications

    • Benedict Panizza
    • Timothy Warren

    Head and Neck Cancers (EY Hanna, Section Editor) 27 December 2012 Pages: 128 - 133

11. Transoral Microsurgery for Treatment of Laryngeal and Pharyngeal Cancers

    • Carlos Suárez
    • Juan P. Rodrigo

    Head and Neck Cancers (EY Hanna, Section Editor) 30 December 2012 Pages: 134 - 141

12. Efficacy of Neck Dissection in the Management of Isolated Nodal Recurrence after Head and Neck Cancer Treatment

    • Jimmy Yu–wai Chan

    Head and Neck Cancers (EY Hanna, Section Editor) 15 January 2013 Pages: 142 - 145

13. Adjuvant Therapy in Gastric Cancer: What Is The Optimal Approach?

    • Takashi Taketa
    • Kazuki Sudo
    • Jaffer A. Ajani

    Gastrointestinal Cancers (BG Czito, Section Editor) 26 January 2013 Pages: 146 - 151

14. Pathological Complete Response After Neoadjuvant Therapy for Rectal Cancer and the Role of Adjuvant Therapy

    • Valerie M. Nelson
    • Al B. Benson III

    Gastrointestinal Cancers (BG Czito, Section Editor) 05 February 2013 Pages: 152 - 161

    

15. Neoadjuvant Therapy for Potentially Resectable Pancreatic Cancer: An Emerging Paradigm?

    • Thomas B. Brunner

    Gastrointestinal Cancers (BG Czito, Section Editor) 17 January 2013 Pages: 162 - 169

    

16. Anal Cancer: Are We Making Progress?

    • Ajay Aggarwal
    • Simon Duke
    • Rob Glynne-Jones

    Gastrointestinal Cancers (BG Czito, Section Editor) 31 January 2013 Pages: 170 - 181

17. The Role of the FOLFIRINOX Regimen for Advanced Pancreatic Cancer

    • Thierry Conroy
    • Céline Gavoille
    • Michel Ducreux

    Gastrointestinal Cancers (BG Czito, Section Editor) 23 January 2013 Pages: 182 - 189